Dyne Therapeutics Inc (DYN) USD0.0001
0.64%- This stock can be held in a
Stocks and Shares ISASell:$23.67
Buy:$23.72
Change:
$1.41 (5.64%)
$1.41 (5.64%)Market closed | Prices delayed by at least 15 minutes
Sell:$23.67
Buy:$23.72
Change:$1.41 (5.64%)
$1.41 (5.64%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 March 2024 | Wildon FarwellOther Level A | Sell Regular sell transaction (market) | 1,030 | $25.58 | $26,347.40 | 150,560 |
| 11 March 2024 | Joshua T BrummPresident/CEO | Sell Option/Award related | 40,072 | $25.42 | $1,018,630.24 | 564,313 |
| 11 March 2024 | Joshua T BrummPresident/CEO | Sell Option/Award related | 9,928 | $26.10 | $259,120.80 | 554,385 |
| 11 March 2024 | Joshua T BrummPresident/CEO | Sell Tax related | 7,769 | $26.12 | $202,926.28 | 546,616 |
| 11 March 2024 | Joshua T BrummPresident/CEO | Sell Regular sell transaction (market) | 8,618 | $25.93 | $223,464.74 | 537,998 |
| 11 March 2024 | Susanna Gatti HighCOO | Sell Tax related | 2,292 | $25.70 | $58,904.40 | 156,800 |
| 11 March 2024 | Oxana BeskrovnayaChief Level Officer | Sell Tax related | 2,081 | $25.70 | $53,481.70 | 152,352 |
| 11 March 2024 | Wildon FarwellOther Level A | Sell Tax related | 1,585 | $25.70 | $40,734.50 | 151,590 |
| 11 March 2024 | Jonathan McNeillSenior Vice President | Sell Option/Award related | 17,825 | $25.48 | $454,181.00 | 141,184 |
| 11 March 2024 | Jonathan McNeillSenior Vice President | Sell Tax related | 1,776 | $25.71 | $45,660.96 | 139,408 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 9 January 2024 | FORBION CAPITAL FUND IV COOPERATIEF UAVenture Capital | Buy Regular purchase transaction | 1,428,571 | $17.50 | $24,999,992.50 | 1,428,571 |
| 27 February 2024 | LP ATLAS VENTURE FUND XIVenture Capital | Sell Regular sell transaction (market) | 272,923 | $24.38 | $6,653,862.74 | 5,878,544 |
| 8 March 2024 | Joshua T BrummPresident/CEO | Sell Option/Award related | 202,238 | $25.30 | $5,116,621.40 | 715,490 |
| 9 January 2024 | FORBION CAPITAL FUND IV COOPERATIEF UAVenture Capital | Buy Regular purchase transaction | 285,714 | $17.50 | $4,999,995.00 | 6,416,793 |
| 8 March 2024 | Joshua T BrummPresident/CEO | Sell Option/Award related | 160,670 | $26.72 | $4,293,102.40 | 554,820 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.